These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 32798968)

  • 1. Modeling the Control of TGF-β/Smad Nuclear Accumulation by the Hippo Pathway Effectors, Taz/Yap.
    Labibi B; Bashkurov M; Wrana JL; Attisano L
    iScience; 2020 Aug; 23(8):101416. PubMed ID: 32798968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Crumbs complex couples cell density sensing to Hippo-dependent control of the TGF-β-SMAD pathway.
    Varelas X; Samavarchi-Tehrani P; Narimatsu M; Weiss A; Cockburn K; Larsen BG; Rossant J; Wrana JL
    Dev Cell; 2010 Dec; 19(6):831-44. PubMed ID: 21145499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TGF-β/Smads signaling pathway, Hippo-YAP/TAZ signaling pathway, and VEGF: Their mechanisms and roles in vascular remodeling related diseases.
    Liu H; Sun M; Wu N; Liu B; Liu Q; Fan X
    Immun Inflamm Dis; 2023 Nov; 11(11):e1060. PubMed ID: 38018603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinct polarity cues direct Taz/Yap and TGFβ receptor localization to differentially control TGFβ-induced Smad signaling.
    Narimatsu M; Samavarchi-Tehrani P; Varelas X; Wrana JL
    Dev Cell; 2015 Mar; 32(5):652-6. PubMed ID: 25758863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Tumor Suppressor CYLD Inhibits Mammary Epithelial to Mesenchymal Transition by the Coordinated Inhibition of YAP/TAZ and TGF Signaling.
    Pseftogas A; Xanthopoulos K; Poutahidis T; Ainali C; Dafou D; Panteris E; Kern JG; Varelas X; Hardas A; Gonidas C; Tsingotjidou A; Hatzivassiliou E; Mosialos G
    Cancers (Basel); 2020 Jul; 12(8):. PubMed ID: 32722292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concurrent YAP/TAZ and SMAD signaling mediate vocal fold fibrosis.
    Nakamura R; Hiwatashi N; Bing R; Doyle CP; Branski RC
    Sci Rep; 2021 Jun; 11(1):13484. PubMed ID: 34188130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Signaling in Fibrosis: TGF-β, WNT, and YAP/TAZ Converge.
    Piersma B; Bank RA; Boersema M
    Front Med (Lausanne); 2015; 2():59. PubMed ID: 26389119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. YAP/TAZ Are Essential for TGF-β2-Mediated Conjunctival Fibrosis.
    Futakuchi A; Inoue T; Wei FY; Inoue-Mochita M; Fujimoto T; Tomizawa K; Tanihara H
    Invest Ophthalmol Vis Sci; 2018 Jun; 59(7):3069-3078. PubMed ID: 30025139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-content imaging and analysis to quantify the nuclear to cytoplasmic ratio of TGFβ and hippo effectors in mammalian cells.
    Labibi B; Bashkurov M; Christova T; Attisano L
    STAR Protoc; 2021 Sep; 2(3):100632. PubMed ID: 34258593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TGF-β/SMAD canonical pathway induces the expression of transcriptional cofactor TAZ in liver cancer cells.
    Ríos-López DG; Tecalco-Cruz AC; Martínez-Pastor D; Sosa-Garrocho M; Tapia-Urzúa G; Aranda-López Y; Ortega-Domínguez B; Recillas-Targa F; Vázquez-Victorio G; Macías-Silva M
    Heliyon; 2023 Nov; 9(11):e21519. PubMed ID: 38027697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Hippo signaling pathway provides novel anti-cancer drug targets.
    Bae JS; Kim SM; Lee H
    Oncotarget; 2017 Feb; 8(9):16084-16098. PubMed ID: 28035075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of the Hippo signalling effectors YAP and TAZ in canine mammary gland hyperplasia and malignant transformation of mammary tumours.
    Rico C; Boerboom D; Paquet M
    Vet Comp Oncol; 2018 Dec; 16(4):630-635. PubMed ID: 30117264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. YAP/TAZ Signaling as a Molecular Link between Fibrosis and Cancer.
    Noguchi S; Saito A; Nagase T
    Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30463366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An evaluation of TAZ and YAP crosstalk with TGFβ signalling in canine osteosarcoma suggests involvement of hippo signalling in disease progression.
    Luu AK; Schott CR; Jones R; Poon AC; Golding B; Hamed R; Deheshi B; Mutsaers A; Wood GA; Viloria-Petit AM
    BMC Vet Res; 2018 Nov; 14(1):365. PubMed ID: 30477496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. WW Domain-Containing Proteins YAP and TAZ in the Hippo Pathway as Key Regulators in Stemness Maintenance, Tissue Homeostasis, and Tumorigenesis.
    Chen YA; Lu CY; Cheng TY; Pan SH; Chen HF; Chang NS
    Front Oncol; 2019; 9():60. PubMed ID: 30805310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. YAP/TAZ: a promising target for squamous cell carcinoma treatment.
    Dong X; Meng L; Liu P; Ji R; Su X; Xin Y; Jiang X
    Cancer Manag Res; 2019; 11():6245-6252. PubMed ID: 31360073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular mechanisms underlying TGF-ß/Hippo signaling crosstalks - Role of baso-apical epithelial cell polarity.
    Ben Mimoun S; Mauviel A
    Int J Biochem Cell Biol; 2018 May; 98():75-81. PubMed ID: 29544895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epithelial Expression of YAP and TAZ Is Sequentially Required in Lung Development.
    Isago H; Mitani A; Mikami Y; Horie M; Urushiyama H; Hamamoto R; Terasaki Y; Nagase T
    Am J Respir Cell Mol Biol; 2020 Feb; 62(2):256-266. PubMed ID: 31486675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Hippo pathway effectors TAZ and YAP in development, homeostasis and disease.
    Varelas X
    Development; 2014 Apr; 141(8):1614-26. PubMed ID: 24715453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The biology of YAP/TAZ: hippo signaling and beyond.
    Piccolo S; Dupont S; Cordenonsi M
    Physiol Rev; 2014 Oct; 94(4):1287-312. PubMed ID: 25287865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.